About, Methodology, and Sources

Direct answer

The Truth About 7-OH is an educational resource focused on concentrated 7-hydroxymitragynine. Our editorial standard is to identify the product, link claims to evidence, and state what remains uncertain.

Research standards

We distinguish botanical leaf, extracts, and intentionally enhanced 7-OH products. The FDA assessment is a starting point for that distinction, not a substitute for reading the underlying studies. FDA 7-OH scientific assessment

We prioritize primary documents and original research. A laboratory result, an animal experiment, a clinical report, and a surveillance signal are labeled as different kinds of evidence. We do not turn detection into proof of causation, anecdotes into population statistics, or assay potency into dosing advice.

How regulatory updates are handled

We link the dated instrument and distinguish recommendations, notices of intent, and effective orders. The October 2026 FDA update and October 14 Federal Register notice are separate documents with different roles. FDA October 2026 7-OH update DEA October 14, 2026 notice of intent

Page review dates do not imply that every cited study was published or revised on that date.

Composite narrative policy

The experience page contains invented illustrative composites, not testimonials or verified case reports. No individual is represented, no private or forum story is reproduced, and no treatment outcome is claimed.

Composites illustrate questions a reader could bring to a clinician. They are not research evidence and cannot establish how common any experience is.

Credentials and limitations

This site does not claim clinician authorship, independent laboratory testing, or medical review that has not occurred. It does not diagnose, treat, prescribe a taper, or replace professional care.

A source link helps readers verify a claim; it does not imply that the source endorses this site. For support, see Get Help.